Your browser doesn't support javascript.
loading
COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.
Peremiquel-Trillas, Paula; Saura-Lázaro, Anna; Benavente-Moreno, Yolanda; Casabonne, Delphine; Loureiro, Eva; Cabrera, Sandra; Duran, Angela; Garrote, Lidia; Brao, Immaculada; Trelis, Jordi; Galán, Maica; Soler, Francesc; Julià, Joaquim; Cortasa, Dolça; Domínguez, Maria Ángeles; Albasanz-Puig, Adaia; Gudiol, Carlota; Ramírez-Tarruella, Dolors; Muniesa, Joan; Rivas, Juan Pedro; Muñoz-Montplet, Carles; Sedano, Ana; Plans, Àngel; Calvo-Cerrada, Beatriz; Calle, Candela; Clopés, Ana; Carnicer-Pont, Dolors; Alemany, Laia; Fernández, Esteve.
Afiliação
  • Peremiquel-Trillas P; Cancer Epidemiology Research Programme, Cancer Epidemiology and Prevention Department, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.
  • Saura-Lázaro A; Epidemiology and Public Health Programme, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
  • Benavente-Moreno Y; CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Casabonne D; School of Medicine and Clinical Sciences, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.
  • Loureiro E; Cancer Epidemiology Research Programme, Cancer Epidemiology and Prevention Department, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.
  • Cabrera S; Epidemiology and Public Health Programme, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
  • Duran A; Cancer Epidemiology Research Programme, Cancer Epidemiology and Prevention Department, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.
  • Garrote L; Epidemiology and Public Health Programme, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
  • Brao I; CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Trelis J; Cancer Epidemiology Research Programme, Cancer Epidemiology and Prevention Department, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.
  • Galán M; Epidemiology and Public Health Programme, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
  • Soler F; CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Julià J; Computer Science Services, Technology & Physics, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.
  • Cortasa D; Computational Science and Artificial Intelligence, Schoolof Computer Science of Coruña, University of Coruña (UDC), Coruña, Spain.
  • Domínguez MÁ; Research Nursing Department, Institut Català d'Oncologia (ICO), Badalona, Spain.
  • Albasanz-Puig A; Nursing Department, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.
  • Gudiol C; Nursing Department, Institut Català d'Oncologia, Badalona, Spain.
  • Ramírez-Tarruella D; Nursing Department, Institut Català d'Oncologia (ICO), Girona, Spain.
  • Muniesa J; School of Medicine and Clinical Sciences, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.
  • Rivas JP; Palliative Care Department and Medical Director, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.
  • Muñoz-Montplet C; Esofagogastric Tumours Functional Unit and Medical Director, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Spain.
  • Sedano A; Pharmacy Service and Medical Director, Institut Català d'Oncologia (ICO), Girona, Spain.
  • Plans À; Palliative Care Department and Medical Director, Institut Català d'Oncologia (ICO), Badalona, Spain.
  • Calvo-Cerrada B; School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Calle C; Medical Director, Institut català d'Oncologia, Tarragona, Spain.
  • Clopés A; Microbiology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.
  • Carnicer-Pont D; Infectious Diseases Programme, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
  • Alemany L; Department of Pathology Experimental Therapeutics, Universitat de Barcelona, L'Hosìtalet de Llobregat, Spain.
  • Fernández E; Infectious Disease Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.
BMJ Open ; 12(4): e056637, 2022 04 21.
Article em En | MEDLINE | ID: mdl-35450905
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article